Next Article in Journal
One-Pot Synthesis of 1-Thia-4-azaspiro[4.4/5]alkan-3-ones via Schiff Base: Design, Synthesis, and Apoptotic Antiproliferative Properties of Dual EGFR/BRAFV600E Inhibitors
Next Article in Special Issue
Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 2019
Previous Article in Journal
Cost-Effectiveness of Targeted Prophylaxis among Allogenic Stem Cell Transplant Recipients
Previous Article in Special Issue
Epidemiology, Patients’ Journey and Healthcare Costs in Early-Stage Non-Small-Cell Lung Carcinoma: A Real-World Evidence Analysis in Italy
 
 
Article

Article Versions Notes

Pharmaceuticals 2023, 16(3), 465; https://doi.org/10.3390/ph16030465
Action Date Notes Link
article xml file uploaded 21 March 2023 15:42 CET Original file -
article xml uploaded. 21 March 2023 15:42 CET Update -
article pdf uploaded. 21 March 2023 15:42 CET Version of Record -
article supplementary file uploaded. 21 March 2023 15:42 CET - https://www.mdpi.com/1424-8247/16/3/465#supplementary
article html file updated 21 March 2023 15:43 CET Original file -
article xml file uploaded 21 March 2023 15:59 CET Update -
article xml uploaded. 21 March 2023 15:59 CET Update https://www.mdpi.com/1424-8247/16/3/465/xml
article pdf uploaded. 21 March 2023 15:59 CET Updated version of record https://www.mdpi.com/1424-8247/16/3/465/pdf
article html file updated 21 March 2023 16:00 CET Update -
article html file updated 6 April 2023 21:27 CEST Update https://www.mdpi.com/1424-8247/16/3/465/html
Back to TopTop